The second mechanism to consider is the influence of SATB1 on the anti-apoptotic marker BCL2, given the documented overexpression of BCL2 in HRS cells of patients with refractory and early relapsed cHL [45]. Here, BCL2 is linked to classic Hodgkin lymphoma.